Lederer & Associates Investment Counsel Vertex Pharmaceuticals Inc Transaction History

Lederer & Associates Investment Counsel

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$187.49 - $221.1 $1.11 Million - $1.31 Million	-5,943 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$207.02 - $241.31 $283,203 - $330,112	1,368 Added 29.9%	5,943 $1.28 Million
Q4 2020 Jan 25, 2021	SELL	$207.01 - $276.09 $484,817 - $646,602	-2,342 Reduced 33.86%	4,575 $1.08 Million
Q3 2020 Jan 13, 2021	BUY	$255.65 - $303.1 $312,148 - $370,085	1,221 Added 21.44%	6,917 $1.88 Million
Q2 2020 Jul 14, 2020	BUY	$225.48 - $295.8 $1.28 Million - $1.68 Million	5,696 New	5,696 $1.65 Million

1,625

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Lederer & Associates Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Lederer & Associates Investment Counsel with notifications on news.